clinical_trials
Supplement Shows Promise for Improving Cancer-Related Cognitive Impairment
Confidence86·multiple reportsImportance88NP-EVT-20261023-A92D908
(MedPage Today) -- Cancer-related cognitive impairment (CRCI) in breast cancer survivors improved significantly after treatment with the glutamate regulator oxaloacetate, a preliminary single-arm clinical study showed. All 16 evaluable patients...
Read the original at the primary source
Supplement Shows Promise for Improving Cancer-Related Cognitive Impairment
10/23/2026, 8:45:19 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —